Curious cases of financial engineering in biotech

7k words, 32 minutes reading time

Primers Curious cases of financial engineering in biotech 7k words, 32 minutes reading time Abhishaike Mahajan Apr 27, 2026 214 9 33 Share Note: finance topics are slightly sensitive, so, while nothing in this article contains proprietary information, I will not include the names of people I talked with for this piece. I appreciate everyone who reached out to help me put this together! Edit: The follow-up to this article has been published: How financial architectures shaped (and will continue to shape) Chinese drug development . Introduction Finance tries to make failure survivable: the Andre

saved by

• Dheera Vuppala
• Jason Black

related reading

• Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
• Companies that should exist - Anastasia Gamickanastasiagamick.substack.com
• Tech vs Biotech - Celine Haliouacelinehh.com
• Biotech’s Dulcius Ex Asperis: The Way Through This Downturn - RApportrapport.bio
• Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
• The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
• Anatomy of a Biotech Business Development Deal | Andreessen Horowitza16z.com
• Where are all the trillion dollar biotechs?ladanuzhna.xyz
• .:: Phrack Magazine ::.phrack.org
• Some questions about biotech that I find interesting | Alex’s blogatelfo.github.io
• The Business of RNAi Therapeutics in 2012ncbi.nlm.nih.gov
• Hub-and-Spoke Biotechs: BridgeBiocenturyofbio.com